Key facts
- Photinia Biosciences’s last known valuation is $14.0M (Sep 2025).
- It has raised $6.6M; the latest was Seed Round ($6.6M) in Sep 2025.
- Notable investors include Red Tree Venture Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Photinia Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Photinia Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Photinia Biosciences
Operator of a radiopharmaceutical company intended to selectively target cancer cells and enable deep tumor penetration.
- Sector
- Healthcare
- HQ
- Redwood City, CA, United States
- Founded
- 2024
- Ownership
- Privately Held (backing)
Photinia Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Photinia Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Photinia Biosciences in its N-PORT filings yet. We sweep new filings monthly.